Engraftment of gene–modified umbilical cord blood cells in neonates with adenosine deaminase deficiency
Nature Medicine1995Vol. 1(10), pp. 1017–1023
Citations Over TimeTop 1% of 1995 papers
Donald B. Kohn, Kenneth I. Weinberg, Jan A. Nolta, Linda N. Heiss, Carl Lenarsky, Gay M. Crooks, Mary E. Hanley, Geralyn Annett, Judith Brooks, Anthony El-Khoureiy, Kim Lawrence, Susie Wells, Robert C. Moen, John F. Bastian, Debora Williams‐Herman, Melissa E. Elder, Diane W. Wara, Thomas J. Bowen, Michael S. Hershfield, Craig A. Mullen, R. Michael Blaese, Robertson Parkman
Related Papers
- → Gene Therapy for Severe Combined Immunodeficiency due to Adenosine Deaminase Deficiency(2012)31 cited
- → Severe Combined Immunodeficiency and Adenosine Deaminase Deficiency(1975)250 cited
- → Severe combined immunodeficiency due to adenosine deaminase deficiency(2020)4 cited
- → Gene therapy for adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID)(2009)1 cited
- → Orphan designation: Autologous CD34+ cells transfected with retroviral vector containing adenosine deaminase gene, Treatment of severe combined immunodeficiency (SCID) due to adenosine deaminase (ADA) deficiency(2018)